Major Depressive Disorder
Showing 51 - 75 of >10,000
MDD Trial in Calgary (D-cycloserine, Transcranial Magnetic Stimulator)
Recruiting
- Major Depressive Disorder
- D-cycloserine
- Transcranial Magnetic Stimulator
-
Calgary, Alberta, CanadaUniversity of Calgary
Feb 16, 2023
MDD Trial in Ames (High Dose Resistance Exercise Training, Low Dose Resistance Exercise Training Group)
Not yet recruiting
- Major Depressive Disorder
- High Dose Resistance Exercise Training
- Low Dose Resistance Exercise Training Group
-
Ames, IowaIowa State University
Oct 31, 2023
MDD Trial in Columbia (TMS treatment)
Completed
- MDD
- TMS treatment
-
Columbia, MissouriUniversity of Missouri Neuromodulation Center
Dec 8, 2022
MDD Trial in Boston (Smartphone-delivered CBT for MDD)
Not yet recruiting
- Major Depressive Disorder
- Smartphone-delivered CBT for MDD
-
Boston, MassachusettsMassachusetts General Hospital
Oct 3, 2022
Treatment Resistant Depression, MDD, MDD Trial in Austin (Psilocybin, Accelerated intermittent theta burst (aiTBS) rTMS
Not yet recruiting
- Treatment Resistant Depression
- +4 more
- Psilocybin
- +3 more
-
Austin, TexasHealth Discovery Building (HDB), 1601 Trinity St., Bldg B., Z060
Nov 14, 2023
MDD Trial (transcranial magnetic stimulation)
Not yet recruiting
- Major Depressive Disorder
- transcranial magnetic stimulation
- (no location specified)
Jun 12, 2023
Study: Psilocybin or Niacin / Major Depressive Disorder
Terminated
- Major Depressive Disorder
- No intervention will be administered as part of this study.
-
Lauderhill, FloridaSegal Trials
Nov 29, 2022
Depression Trial run by the National Institute of Mental Health (NIMH) (18F-PF-06445974)
Recruiting
- Depression
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 3, 2023
Prospective Clinical Cohort Study of Depression
Not yet recruiting
- Major Depressive Disorder
- selective serotonin reuptake inhibitors
- TMS
- (no location specified)
Mar 7, 2023
Healthy Volunteer, MDD, Depression Trial run by the NIMH (drug, other, device)
Recruiting
- Healthy Volunteer
- +2 more
- Ketamine
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 12, 2023
MDD, Alcohol Use Disorder Trial in Baltimore (Psilocybin, Placebo)
Recruiting
- Major Depressive Disorder
- Alcohol Use Disorder
- Psilocybin
- Placebo
-
Baltimore, MarylandJohns Hopkins Center for Psychedelic and Consciousness Research
Aug 29, 2022
MDD Trial (Open-label TMS)
Not yet recruiting
- Major Depressive Disorder
- Open-label TMS
- (no location specified)
Dec 1, 2022
MDD Trial in New York (Fisher Wallace Cranial Electrotherapy Stimulator (Active Device), Fisher Wallace Cranial Electrotherapy
Completed
- Major Depressive Disorder
- Fisher Wallace Cranial Electrotherapy Stimulator (Active Device)
- Fisher Wallace Cranial Electrotherapy Stimulator (Placebo Device)
-
New York, New YorkNew York Neuromodulation Medical, PLLC
Nov 3, 2022
MDD Trial in Hangzhou (SSRI, SIA, AIA)
Recruiting
- Major Depressive Disorder
- SSRI
- +2 more
-
Hangzhou, Zhejiang, Chinathe Third affiliated hospital of Zhejiang Chinese Medical univer
Jan 31, 2023
MDD Trial in San Francisco (Intervention app, Control app)
Not yet recruiting
- Major Depressive Disorder
- Intervention app
- Control app
-
San Francisco, CaliforniaBig Health, Inc.
Aug 29, 2023
MDD, Chronic Pain Trial in Los Angeles (Active rTMS/Active iTBS DFPLC/Sham Pain M1, Sham rTMS/ Active iTBS Pain, Active
Not yet recruiting
- Major Depressive Disorder
- Chronic Pain
- Active rTMS/Active iTBS DFPLC/Sham Pain M1
- +2 more
-
Los Angeles, CaliforniaUCLA Semel Institute
Oct 11, 2022
Depressive Disorder, Major, Self-Injurious Behavior Trial in Porto Alegre (Transcranial Magnetic Stimulation (TMS), Sham)
Recruiting
- Depressive Disorder, Major
- Self-Injurious Behavior
- Transcranial Magnetic Stimulation (TMS)
- Sham
-
Porto Alegre, RS, BrazilInstituto do Cérebro do Rio Grande do Sul
Oct 25, 2023
MDD, Inflammation Trial in Duffel, Brussels, Leuven (Celecoxib, Minocyclin, Placebo)
Not yet recruiting
- Major Depressive Disorder
- Inflammation
- Celecoxib
- +2 more
-
Duffel, Antwerpen, Belgium
- +2 more
Dec 8, 2022
Accexible as a Tool for Screening and Monitoring Depression.
Recruiting
- Major Depressive Disorder (MDD)
- Accexible
-
Barcelona, SpainVall d'Hebron Institut de Investigación (VHIR)
Sep 18, 2023
MDD Trial in Providence (EMA Monitoring, Scheduling Maintenance TMS sessions)
Recruiting
- Major Depressive Disorder
- EMA Monitoring
- Scheduling Maintenance TMS sessions
-
Providence, Rhode IslandButler Hospital
Nov 28, 2023
MDD Trial in New York (SEP-363856, Placebo)
Recruiting
- Major Depressive Disorder
- SEP-363856
- Placebo
-
New York, New YorkFor additional information regarding sites, contact 844-687-8522
Nov 14, 2022